{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:47:14Z","timestamp":1761929234107},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.actatropica.2005.01.005","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T04:35:31Z","timestamp":1108096531000},"page":"311-316","source":"Crossref","is-referenced-by-count":40,"title":["Anti-trypanosomal activities of DNA topoisomerase inhibitors"],"prefix":"10.1016","volume":"93","author":[{"given":"Alexander","family":"Deterding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona A.","family":"Dungey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy-Anne","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Steverding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2005.01.005_bib1","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1021\/bi9624898","article-title":"DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin","volume":"36","author":"Bailly","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.actatropica.2005.01.005_bib2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/j.1460-2075.1985.tb03772.x","article-title":"Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense","volume":"4","author":"Baltz","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.actatropica.2005.01.005_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0169-4758(99)01560-4","article-title":"Anti-sleeping sickness drugs and cancer chemotherapy","volume":"16","author":"Barrett","year":"2000","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.actatropica.2005.01.005_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0006-2952(94)00465-X","article-title":"Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells","volume":"49","author":"Benchokroun","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.actatropica.2005.01.005_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/379225a0","article-title":"Structure and mechanism of DNA topoisomerase II","volume":"379","author":"Berger","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2005.01.005_bib6","unstructured":"BNF, 2002. British National Formulary (44th ed.). British Medical Association and Royal Pharmaceutical Society of Great Britain, 416\u2013417."},{"key":"10.1016\/j.actatropica.2005.01.005_bib7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0006-2952(95)00215-L","article-title":"Antitrypanosomal activity of camptothecin analogs. Structure\u2013activity correlations","volume":"50","author":"Bodley","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.actatropica.2005.01.005_bib8","first-page":"535","article-title":"Differential actions of aclarubicin and doxorubicin: the role of topoisomerase I","volume":"9","author":"Bridewell","year":"1997","journal-title":"Oncol. Res."},{"key":"10.1016\/j.actatropica.2005.01.005_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/01635589509514368","article-title":"The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro","volume":"23","author":"Constantinou","year":"1995","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.actatropica.2005.01.005_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0006-291X(86)90471-7","article-title":"Mitoxantrone affects topoisomerase activities in human breast cancer cells","volume":"136","author":"Crespi","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actatropica.2005.01.005_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2005.01.005_bib12","doi-asserted-by":"crossref","first-page":"16455","DOI":"10.1074\/jbc.271.28.16455","article-title":"The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome","volume":"271","author":"Figueiredo-Pereira","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2005.01.005_bib13","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1074\/jbc.270.25.14998","article-title":"Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy","volume":"270","author":"Froelich-Ammon","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2005.01.005_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-8741(03)00192-2","article-title":"Cytotoxic effect of Plantago spp. on cancer cell lines","volume":"88","author":"G\u00e1lvez","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.actatropica.2005.01.005_bib15","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","article-title":"Etoposide: four decades of development of a topoisomerase II inhibitor","volume":"34","author":"Hande","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.actatropica.2005.01.005_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0031182000000822","article-title":"In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei","volume":"80","author":"Hirumi","year":"1980","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2005.01.005_bib17","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2005.01.005_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2005.01.005_bib19","doi-asserted-by":"crossref","first-page":"22463","DOI":"10.1016\/S0021-9258(18)41552-9","article-title":"\u03b2-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin","volume":"268","author":"Li","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2005.01.005_bib20","first-page":"23","article-title":"DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells","volume":"11","author":"Ling","year":"1990","journal-title":"Cancer Biochem. Biophys."},{"key":"10.1016\/j.actatropica.2005.01.005_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1568011023354218","article-title":"Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649 and fluoroindolocarbazoles","volume":"2","author":"Long","year":"2002","journal-title":"Curr. Med. Chem. Anti-Canc. Agents"},{"key":"10.1016\/j.actatropica.2005.01.005_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1286-4579(01)01432-0","article-title":"Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle","volume":"3","author":"Matovu","year":"2001","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2005.01.005_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2001-17351","article-title":"In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense","volume":"67","author":"Merschjohann","year":"2001","journal-title":"Planta Med."},{"key":"10.1016\/j.actatropica.2005.01.005_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00001813-199709000-00003","article-title":"Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo","volume":"8","author":"Morris","year":"1997","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.actatropica.2005.01.005_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0167-4781(98)00128-6","article-title":"Investigating the biological functions of DNA topoisomerases in eukaryotic cells","volume":"1400","author":"Nitiss","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actatropica.2005.01.005_bib26","first-page":"4564","article-title":"Aclacinomycin A stabilizes topoisomerase I covalent complexes","volume":"57","author":"Nitiss","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.actatropica.2005.01.005_bib27","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1128\/AAC.46.6.2038-2040.2002","article-title":"Antitrypanosomal activities of proteasome inhibitors","volume":"46","author":"Nkemgu-Njinkeng","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2005.01.005_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0924-8579(03)00096-7","article-title":"Improved trypanocidal activities of cathepsin L inhibitors","volume":"22","author":"Nkemngu","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2005.01.005_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008270717294","article-title":"Topoisomerase I inhibitors: review and update","volume":"8","author":"Rothenberg","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.actatropica.2005.01.005_bib30","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/0006-2952(85)90530-1","article-title":"Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage","volume":"34","author":"Rowe","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.actatropica.2005.01.005_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-199549010-00002","article-title":"Topoisomerase inhibitors. A review of their therapeutic potential in cancer","volume":"49","author":"Sinha","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.actatropica.2005.01.005_bib32","first-page":"1157","article-title":"Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions","volume":"25","author":"Slatter","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.actatropica.2005.01.005_bib33","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.279.5356.1534","article-title":"A model for the mechanism of human topoisomerase I","volume":"279","author":"Stewart","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2005.01.005_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-4781(98)00130-4","article-title":"Clinical applications of the camptothecins","volume":"1400","author":"Takimoto","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actatropica.2005.01.005_bib35","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1091\/mbc.E02-05-0266","article-title":"Mitochondrial development during life cycle differentiation of African trypanosomes: evidence for a kinetoplast-dependent differentiation control point","volume":"13","author":"Timms","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.actatropica.2005.01.005_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2710.2001.00368.x","article-title":"DNA topoisomerases as targets for anticancer drugs","volume":"26","author":"Topcu","year":"2001","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.actatropica.2005.01.005_bib37","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2005.01.005_bib38","first-page":"38","article-title":"Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II","volume":"38","author":"Wassermann","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.actatropica.2005.01.005_bib39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm0902-908b","article-title":"Resurrecting the resurrection drug","volume":"8","author":"Wickware","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.actatropica.2005.01.005_bib40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.13.5.735","article-title":"Trypanocidal activity of antitumor antibiotics and other metabolic inhibitors","volume":"13","author":"Williamson","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2005.01.005_bib41","unstructured":"WHO, 2001. African trypanosomiasis or sleeping sickness. World Health Org. Fact Sheet 259. (http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/)."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X05000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X05000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T01:33:19Z","timestamp":1625448799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X05000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0001706X05000252"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2005.01.005","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}